ES2020171A4 - Eteres de 1-bencilo-3-hidroxilometilo-indazol con 2-hidroxiloacido - Google Patents

Eteres de 1-bencilo-3-hidroxilometilo-indazol con 2-hidroxiloacido

Info

Publication number
ES2020171A4
ES2020171A4 ES90200167T ES90200167T ES2020171A4 ES 2020171 A4 ES2020171 A4 ES 2020171A4 ES 90200167 T ES90200167 T ES 90200167T ES 90200167 T ES90200167 T ES 90200167T ES 2020171 A4 ES2020171 A4 ES 2020171A4
Authority
ES
Spain
Prior art keywords
hydroxylomethyl
hydroxylocide
indazol
ethers
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES90200167T
Other languages
English (en)
Other versions
ES2020171T3 (es
Inventor
Leandro Baiocchi
Bruno Silvestrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of ES2020171A4 publication Critical patent/ES2020171A4/es
Application granted granted Critical
Publication of ES2020171T3 publication Critical patent/ES2020171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES90200167T 1989-02-07 1990-01-23 Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos. Expired - Lifetime ES2020171T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
ES2020171A4 true ES2020171A4 (es) 1991-08-01
ES2020171T3 ES2020171T3 (es) 1995-12-01

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90200167T Expired - Lifetime ES2020171T3 (es) 1989-02-07 1990-01-23 Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.

Country Status (36)

Country Link
US (2) US4999367A (es)
EP (1) EP0382276B1 (es)
JP (1) JP2870925B2 (es)
KR (1) KR0145525B1 (es)
CN (2) CN1046505C (es)
AR (1) AR247386A1 (es)
AT (1) ATE127115T1 (es)
AU (1) AU624895B2 (es)
BG (1) BG50273A3 (es)
CA (1) CA2009503C (es)
CZ (1) CZ280121B6 (es)
DD (2) DD291995A5 (es)
DE (2) DE382276T1 (es)
DK (1) DK0382276T3 (es)
EG (1) EG19170A (es)
ES (1) ES2020171T3 (es)
FI (1) FI102678B1 (es)
GE (1) GEP19971030B (es)
GR (2) GR910300073T1 (es)
HU (1) HU204793B (es)
IL (1) IL93132A (es)
IN (1) IN170957B (es)
IT (1) IT1230441B (es)
LT (1) LT3604B (es)
LV (1) LV10612B (es)
NZ (1) NZ232258A (es)
PE (1) PE25091A1 (es)
PH (1) PH26552A (es)
PL (2) PL163730B1 (es)
PT (1) PT93067B (es)
RO (1) RO106252B1 (es)
RU (3) RU2066318C1 (es)
SK (1) SK56390A3 (es)
UA (1) UA26852C2 (es)
YU (1) YU47943B (es)
ZA (1) ZA90644B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2009221089B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
LT2262778T (lt) 2008-03-07 2019-11-11 Acraf 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška
KR101581829B1 (ko) 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸인다졸 유도체들 및 mcp-1 및 cx3cr1의 발현을 기초로 한 질환들의 치료에서 이의 용도
CN106518769A (zh) 2009-08-03 2017-03-22 方济各安吉利克化学联合股份有限公司 1‑苄基‑3‑羟甲基‑1h‑吲唑及其衍生物以及所需镁中间体的制备方法
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA2911041C (en) 2012-05-01 2020-12-15 Shelley Romayne BOYD Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
EP2850062B1 (en) 2012-05-18 2017-07-19 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SG11201407210SA (en) 2012-05-18 2014-12-30 Sanofi Sa Pyrazole derivatives and their use as lpar5 antagonists
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
US11753382B2 (en) 2019-06-25 2023-09-12 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
BG50273A3 (en) 1992-06-15
EP0382276B1 (en) 1995-08-30
LV10612A (lv) 1995-04-20
RU2044729C1 (ru) 1995-09-27
CN1034016C (zh) 1997-02-12
KR0145525B1 (ko) 1998-08-17
SK278441B6 (en) 1997-05-07
CA2009503A1 (en) 1990-08-07
DE69021902D1 (de) 1995-10-05
AU4906690A (en) 1990-08-16
FI102678B (fi) 1999-01-29
ATE127115T1 (de) 1995-09-15
AU624895B2 (en) 1992-06-25
US4999367A (en) 1991-03-12
EP0382276A2 (en) 1990-08-16
RO106252B1 (ro) 1993-03-31
IN170957B (es) 1992-06-20
YU47943B (sh) 1996-07-24
DK0382276T3 (da) 1996-01-15
HUT53088A (en) 1990-09-28
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
CZ280121B6 (cs) 1995-11-15
PT93067B (pt) 1995-12-29
AR247386A1 (es) 1994-12-29
LT3604B (en) 1995-12-27
FI900577A0 (fi) 1990-02-06
UA26852C2 (uk) 1999-12-29
CA2009503C (en) 2000-04-11
LV10612B (en) 1995-08-20
IL93132A (en) 1994-05-30
US5112986A (en) 1992-05-12
CN1088201A (zh) 1994-06-22
GR910300073T1 (en) 1991-11-15
SK56390A3 (en) 1997-05-07
ES2020171T3 (es) 1995-12-01
DD291995A5 (de) 1991-07-18
PE25091A1 (es) 1991-08-17
HU204793B (en) 1992-02-28
CN1044810A (zh) 1990-08-22
PH26552A (en) 1992-08-19
DD295363A5 (de) 1991-10-31
EP0382276A3 (en) 1990-12-12
CZ56390A3 (en) 1995-06-14
PL163720B1 (pl) 1994-04-29
IT8947620A0 (it) 1989-02-07
NZ232258A (en) 1991-06-25
DE69021902T2 (de) 1996-05-23
HU900689D0 (en) 1990-04-28
PL163730B1 (pl) 1994-04-29
JP2870925B2 (ja) 1999-03-17
RU2066318C1 (ru) 1996-09-10
RU2055071C1 (ru) 1996-02-27
ZA90644B (en) 1991-01-30
EG19170A (en) 1994-11-30
LTIP872A (en) 1995-03-27
KR900012913A (ko) 1990-09-03
IL93132A0 (en) 1990-11-05
PT93067A (pt) 1990-08-31
DE382276T1 (de) 1991-11-28
YU20690A (sh) 1992-07-20
IT1230441B (it) 1991-10-23
JPH02240065A (ja) 1990-09-25
GR3018165T3 (en) 1996-02-29
CN1046505C (zh) 1999-11-17

Similar Documents

Publication Publication Date Title
BR9002634A (pt) Poli-alfa-olefina
DE69032974D1 (de) Empfänger
ES2020171A4 (es) Eteres de 1-bencilo-3-hidroxilometilo-indazol con 2-hidroxiloacido
BR9000014A (pt) Classificaodr
DD294367A5 (de) Farbbildroehre
BR9000539A (pt) Estrutura de anodo
BR9001818A (pt) Girotrom quase-otico
DE59010414D1 (de) Fluorphenylpyridine
BR9006503A (pt) Copolimero agrilamidios
DD284561A5 (de) Chiptraeger
BR8902801A (pt) Vesete
BR8900751A (pt) Operculo anti-aglutinante
BR9007459A (pt) Aparelho digitalizador
BR8906628A (pt) Chin-car
BR8906438A (pt) Super-domino
BR8906303A (pt) Fleximetro
BR8906265A (pt) Aspersorio
BR8905416A (pt) Continuador
BR8905026A (pt) Babadouro multiutilitario
BR8904521A (pt) Arquinho
BR8904228A (pt) Saia-abajur
BR8901287A (pt) Semeadeira-intercaladora
BR8903923A (pt) Form-facil
BR8902938A (pt) Letramatica
DE3991666T1 (de) Glaettbohrer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 382276

Country of ref document: ES